Sei Investments Co. increased its stake in Humana Inc. (NYSE:HUM) by 22.7% during the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 26,416 shares of the insurance provider’s stock after buying an additional 4,884 shares during the period. Sei Investments Co.’s holdings in Humana were worth $6,354,000 at the end of the most recent reporting period.
Several other large investors also recently added to or reduced their stakes in the company. Guardian Life Insurance Co. of America boosted its stake in Humana by 0.7% in the first quarter. Guardian Life Insurance Co. of America now owns 575 shares of the insurance provider’s stock valued at $119,000 after buying an additional 4 shares during the period. Reliance Trust Co. of Delaware boosted its stake in Humana by 0.7% in the second quarter. Reliance Trust Co. of Delaware now owns 1,123 shares of the insurance provider’s stock valued at $270,000 after buying an additional 8 shares during the period. Creative Planning boosted its stake in Humana by 0.3% in the second quarter. Creative Planning now owns 4,874 shares of the insurance provider’s stock valued at $1,173,000 after buying an additional 15 shares during the period. Sit Investment Associates Inc. boosted its stake in Humana by 0.3% in the second quarter. Sit Investment Associates Inc. now owns 12,020 shares of the insurance provider’s stock valued at $2,892,000 after buying an additional 40 shares during the period. Finally, AE Wealth Management LLC boosted its stake in Humana by 3.8% in the first quarter. AE Wealth Management LLC now owns 1,305 shares of the insurance provider’s stock valued at $269,000 after buying an additional 48 shares during the period. Institutional investors and hedge funds own 99.13% of the company’s stock.
Shares of Humana Inc. (NYSE:HUM) opened at 246.83 on Wednesday. The firm has a 50-day moving average price of $240.31 and a 200 day moving average price of $223.89. Humana Inc. has a 12-month low of $163.50 and a 12-month high of $255.27. The firm has a market cap of $35.67 billion, a price-to-earnings ratio of 20.31 and a beta of 0.91.
Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, August 2nd. The insurance provider reported $3.49 EPS for the quarter, topping the Zacks’ consensus estimate of $3.08 by $0.41. Humana had a return on equity of 15.85% and a net margin of 3.37%. The company had revenue of $13.53 billion for the quarter, compared to the consensus estimate of $13.61 billion. During the same quarter in the previous year, the business earned $2.30 EPS. On average, equities research analysts anticipate that Humana Inc. will post $11.55 earnings per share for the current fiscal year.
Several equities research analysts have recently commented on the company. Cowen and Company restated an “outperform” rating and set a $230.00 price target on shares of Humana in a research note on Tuesday, April 25th. Leerink Swann upped their price target on Humana from $250.00 to $265.00 and gave the stock an “outperform” rating in a research note on Tuesday, May 30th. Zacks Investment Research upgraded Humana from a “hold” rating to a “buy” rating and set a $257.00 price target for the company in a research note on Thursday, May 25th. BidaskClub cut Humana from a “buy” rating to a “hold” rating in a research note on Tuesday, June 13th. Finally, UBS AG restated a “neutral” rating and set a $237.00 price target (up previously from $205.00) on shares of Humana in a research note on Wednesday, June 28th. One analyst has rated the stock with a sell rating, nine have given a hold rating and twelve have given a buy rating to the company. Humana currently has an average rating of “Buy” and an average target price of $243.65.
In other news, VP M Todoroff Christopher sold 22,935 shares of the business’s stock in a transaction on Thursday, August 10th. The stock was sold at an average price of $252.52, for a total value of $5,791,546.20. Following the sale, the vice president now owns 24,001 shares of the company’s stock, valued at approximately $6,060,732.52. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Bruce D. Broussard sold 12,000 shares of the business’s stock in a transaction on Friday, August 11th. The stock was sold at an average price of $251.88, for a total value of $3,022,560.00. Following the completion of the sale, the chief executive officer now directly owns 80,086 shares in the company, valued at approximately $20,172,061.68. The disclosure for this sale can be found here. Insiders sold a total of 41,406 shares of company stock worth $10,355,086 in the last three months. Company insiders own 0.80% of the company’s stock.
About Humana
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Receive News & Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related companies with MarketBeat.com's FREE daily email newsletter.
